678 results on '"Arat, Mutlu"'
Search Results
152. Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
153. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
154. Allojeneik hematopoietik hücre naklinde gözlenen tiroid fonksiyon bozuklukları Thyroid dysfunction after allogeneic hematopoietic stem cell transplantation
155. Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplants for Patients with Hodgkin disease: A Comparative Study of the LWP EBMT
156. Post-Transplant Cyclophosphamide (PTCY) Compared to ATG in Patients with Myelodysplastic Neoplasms Allografted with an Unrelated Donor: A Registry Study of the Chronic Malignancies Working Party of the EBMT
157. Prognostic Factors Impacting Post-Transplant Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia: A Registry-Based Study By the EBMT Acute Leukemia Working Party
158. Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience
159. Salvage Transplant Versus CAR-T Cell Therapy for Relapsed Multiple Myeloma
160. Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates
161. The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?
162. Clinical use of hematopoietic stem cells
163. Allogeneic stem cell transplantation for acquired pure red cell aplasia.
164. 498 - Is There Any Room for Allogeneic Hematopoetic Stem Cell Transplantation in Relapse/Refractory Lymphoma: Single Center Experience
165. 424 - Should We Start Peripheral Blood Stem Cell Collection for Allogeneic Transplantation on the Fifth Day?
166. Klinik Uygulamada Hematoloji
167. The Impact of Foundation of the National Turkish Donor Registry, Turkok on Donor Matching Kinetics
168. Validation of Scores Predicting Non-Relapse Mortality in Patients with Myelodysplastic Syndrome: A Study on 1276 Patients on Behalf the Chronic Malignancies Working Party of the EBMT
169. Impact of In Vivo T-Cell Depletion in Patients with Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Registry Study from the Chronic Malignancies Working Party of the EBMT
170. Influence of Past Invasive Fungal Infections on Allogeneic Related Donor Hematopoietic Cell Transplantation Outcome in AML
171. Allogeneic Related Donor Hematopoietic Cell Transplantation in AML CR1: Beware of Past Invasive Fungal Infections
172. 352 - Allogenenic Hematopoetic Cell Transplantation in AML at CR1: Related vs Unrelated vs Haploidentical Donors
173. Hematopoietik Hücre Transplantasyonu Öncesi Periodontal Tedavilerin Engraftman Süreleri Üzerine Etkisi: Vaka Kontrollü Klinik Değerlendirme
174. Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1)
175. Allogeneic Stem Cell Transplantation For Primary Refractory Hodgkin's Disease: Ablative Vs Reduced Intensity
176. Autologous Stem Cell Collection In Lymphoma and Myeloma Patients: Single Center Analysis With Intention To Successful Mobilization and Collection Under Restricted Permission For Use Of Plerixafor
177. Periferik kök hücre ürünlerinin kontrollü dondurma cihazı veya sıvı azotun buhar fazında dondurulmasının hematopoietik kök hücrelerin canlılığına ve çoğalma yeteneklerine etkisinin karşılaştırılması
178. Vanishing bile duct syndrome after allogeneic bone marrow transplantation: Is it the end of the road?
179. Comparison of allogeneic stem cell transplantations in chronic myeloid leukemia before and after the era of tyrosine kinase inhibitors.
180. Intramural Duodenal Haematoma After Upper Gastrointestinal Endoscopic Biopsy in a Bone Marrow Transplant Recipient
181. Kronik lenfositer lösemi ve düşük dereceli Non-Hodking lenfomalarda yüzey antijenlerinin ve adhezyon moleküllerinin expresyonu
182. Intramesenteric Steroid Application for Steroid Refractory Gastrointestinal Graft versus Host Disease
183. A survey of hematologists on compulsory health service in Turkey
184. Paternity Wishes in Young Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation. A Study of the Late Effects Working Party of the EBMT
185. Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients
186. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules
187. Late-Onset Noninfectious Pulmonary Complications in Adult Allogeneic Hematopoietic Cell Transplant Recipients
188. Enzyme replacement therapy in type 1 Gaucher disease and a review of the literature
189. Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
190. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndrome: A Retrospective Validation From a Single Centre.
191. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy☆
192. A Prospective Study on the Feasibility of Related and Unrelated Donor Search and Hematopoietic Cell Transplantation for Adults with Acute Leukemia at 31 European Transplant Centers
193. Flow Cytometric Analysis of T Cell Functions in CML Patients Under Imatinib Therapy
194. Factors Involved in Response to Thalidomide in Myelodysplastic Syndrome: Impace of HLA and Prognostic Factors
195. A Case Report of the Modified Malmö Protocol: An Alternative Therapeutic Approach to Refractory Chronic Idiopathic Thrombocytopenic Purpura
196. Adjuvant Therapeutic Plasma Exchange in Liver Failure
197. Vitiligo after Hematopoietic Cell Transplantation: Six Cases and Review of the Literature
198. Amplitude of Response, Early Mobilization (M) and Pre-Autologous Transplant (ASCT) Use of Bortezomib (V) and/or Thalidomide (T) Are Predictors of Longer Progression Free (PFS) and/or Overall Survival (OS) in Myeloma.
199. Selected papers from the 15th Congress of the Interdisciplinary European Society for Hemapheresis and Hemotherapy
200. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.